Ebola vaccine trial begins in DR Congo

Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo


Discover more from UM LEGACY PRESS LTD

Subscribe to get the latest posts sent to your email.

Discover more from UM LEGACY PRESS LTD

Subscribe now to keep reading and get access to the full archive.

Continue reading